Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells
MILLER, Todd W, FORBES, James T, COOK, Rebecca S, KENNEDY, J. Phillip, LINDSLEY, Craig W, ARTEAGA, Carlos L, SHAH, Chirayu, WYATT, Shelby K, MANNING, H. Charles, OLIVARES, Maria G, SANCHEZ, Violeta, DUGGER, Teresa C, DE MATOS GRANJA, Nara, NARASANNA, Archana
Published in Clinical cancer research (01.12.2009)
Published in Clinical cancer research (01.12.2009)
Get full text
Journal Article
Heritable Variation of ERBB2 and Breast Cancer Risk
BREYER, Joan P, SANDERS, Melinda E, GAO, Yu-Tang, PAGE, David L, DUPONT, William D, WEI ZHENG, SMITH, Jeffrey R, AIREY, David C, QIUYIN CAI, YASPAN, Brian L, SCHUYLER, Peggy A, QI DAI, BOULOS, Fouad, OLIVARES, Maria G, BRADLEY, Kevin M
Published in Cancer epidemiology, biomarkers & prevention (01.04.2009)
Published in Cancer epidemiology, biomarkers & prevention (01.04.2009)
Get full text
Journal Article
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation
Bauer, Joshua A, Chakravarthy, A Bapsi, Rosenbluth, Jennifer M, Mi, Deming, Seeley, Erin H, De Matos Granja-Ingram, Nara, Olivares, Maria G, Kelley, Mark C, Mayer, Ingrid A, Meszoely, Ingrid M, Means-Powell, Julie A, Johnson, Kimberly N, Tsai, Chiaojung Jillian, Ayers, Gregory D, Sanders, Melinda E, Schneider, Robert J, Formenti, Silvia C, Caprioli, Richard M, Pietenpol, Jennifer A
Published in Clinical cancer research (15.01.2010)
Published in Clinical cancer research (15.01.2010)
Get full text
Journal Article
Abstract 698: Overexpression of the aryl hydrocarbon receptor correlates with high tumor grade in human breast invasive carcinomas
Eltom, Sakina E., Prins, Petra, Olivares, Maria G., Ballard, Billy R., Johnson, Kimberly N., Granja-Ingram, Nara D., Agboto, Vincent K., Ding, Tan
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Inhibition of mTOR is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells
Miller, Todd W., Forbes, James T., Shah, Chirayu, Wyatt, Shelby K., Manning, H. Charles, Olivares, Maria G., Sanchez, Violeta, Dugger, Teresa C., Granja, Nara de Matos, Narasanna, Archana, Cook, Rebecca S., Kennedy, J. Phillip, Lindsley, Craig W., Arteaga, Carlos L.
Published in Clinical cancer research (24.11.2009)
Published in Clinical cancer research (24.11.2009)
Get full text
Journal Article